Search
for
Sort by
Research 421–450 of 1000+
- 27604 Response to baricitinib in the treatment of patients with early and late onset alopecia areata in the phase 2 portion of BRAVE-AA1 randomized controlled trial
- Niche-dependent immunometabolic regulation of tissue repair and regeneration
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Nanoflow UHPLC-MS3 for sensitive detection of cortisol in a single-strand 1-cm human hair segment
- Novel tissue mechanics-guided cellular flows drive the formation of feather follicles
- Transcriptome-guided development of a fibrosis-reversal compound reduces skin scarring and allows regeneration via mitochondrial uncoupling
- Dissolving microneedles incorporating kopexil multicomponent crystals for improved transdermal delivery
- Wearable textile-based phototherapy platform with customized NIR OLEDs toward non-invasive hair loss treatment
- Metabolomic and lipidomic atlas of human hair across its length
- Novel Tissue Mechanics-Guided Cellular Flows Enable the Evolution of Feather Follicles
- 61537 No Increased Risk of Breast or Gynecologic Cancers in Women with 5α-Reductase Inhibitor Exposure for Female Pattern Hair Loss: A Population-Based Propensity Score-Matched Cohort Study
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- M2 Macrophage and Extracellular Matrix Genes Are Enriched in High‐Activity Lichen Planopilaris
- 523 Targeting NETosis to treat delayed wound healing in a humanized mouse model of sickle cell disease
- Patient Considerations when Using Ritlecitinib for Alopecia Areata in Adolescents: Guidance for the Clinicians
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- 54306 Use of Music During Scalp Injections: A Preliminary Study
- “Downy hair sign”—A clue to autoimmune disease in curly hair
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Vitiligo and Alopecia Areata After Donor Lymphocyte Infusions in a Child With Relapsed Acute Myeloid Leukemia
- Response to Bhoyrul B., “The treatment of primary cicatricial alopecia is challenging”
- 151 Efficacy and adverse effects of oral Janus kinase inhibitor (JAKi) use in patients with lichen planopilaris: a retrospective case series and systematic review
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- 42863 The association of milia-like calcinosis cutis, alopecia totalis and hyperthyroidism linked with the novel mutation for RBM28
- 42146 Concurrent improvement in scalp hair and eyebrow or eyelash regrowth in patients with severe alopecia areata treated with baricitinib
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Potential Natural Products Regulation of Molecular Signaling Pathway in Dermal Papilla Stem Cells
- ISID0197 - Quantitative analysis of hair loss in mice utilizing imageJ improves the efficacy evaluation of alopecia areata induction in the C3H/HeJ mouse model
- 1444 Harnessing the potential of fetal microchimeric cells to improve maternal wound healing
- Data from Mobilizing Transit-Amplifying Cell-Derived Ectopic Progenitors Prevents Hair Loss from Chemotherapy or Radiation Therapy